Lycopodium Limited
ASX: LYL
EPCM growth and the SAXUM acquisition drive Lycopodium’s strong financial performance.
(Source: TradingView) 3-Month Performance Profile of LYL on a DTF compared to S&P/ASX 200 (XJO).
Lycopodium achieved solid financial results in FY2025, reporting a Net Profit After Tax of $42.2 million and a 37.4% year-on-year increase in operating cash flow to $38.27 million
🔒
Subscribers only
Sign in with your subscriber account or subscribe to access this research report.
Required subscription
Daily Digest
A$200.00
Already a subscriber?
Sign in to read this report.
Required subscription
Daily Digest
Stay informed with expert daily ASX research covering four carefully selected stocks, complete with market insights, risk ratings, and clear Buy, Hold, or Sell general guidance—delivered before the market opens each trading day.
- ✓ Four Expert-Selected ASX Stocks Daily
- ✓ Weekday Pre-Market Delivery
- ✓ In-Depth Research & Analysis
- ✓ Access to All Previous Reports
A$200.00/ 12 months
Risk:Medium
Subscribe Now →
